Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR

PHASE4CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Intraoperative BleedingPost-operative Bleeding
Interventions
DRUG

Floseal

Floseal (5 milliliters) will be applied to the exposed bone in the following order: around the margins of the tibia, the femur (anterior surface, intercondylar notch, exposed medial and lateral condyles) and around the un resurfaced portion of the patella. The other syringes (each of 5 milliliters) will then be applied to the supra-patellar synovium and into the medial and lateral gutters of the knee. No Floseal will be applied outside the knee joint capsule.

Trial Locations (1)

H4J 1C5

Hopital du sacre coeur de montreal, Montreal

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER

NCT01891461 - Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR | Biotech Hunter | Biotech Hunter